Conversational Interface CASE Tool

[Michael DeVries]

ms izzy’s webinars on benzinga:

• ms izzy webinar => https://benzinga.wistia.com/medias/x34gylz5vq
• Benzinga PRO Webinar: Ms. Izzy | A Trader’s Journey From Start to Pro Trader. => https://www.youtube.com/watch?v=EPHDGJUbNK4&feature=youtu.be

by ms izzy on Twitter @_ms_izzy on YouTube at: https://www.youtube.com/channel/UCRaf6UJFiINLUv1U1G8Esxg/videos

What other Good Trading Videos, Webinars, etc. have You Found and would You Recommend?

Please Share them All herein for Everyone’s Benefit, ok?

I hope this all helps! Good Luck! and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

A MUST WATCH LESSON ON STOP LOSSES & RISK MANAGEMENT => https://www.youtube.com/watch?v=E20TB9t_hyU&t=2s

by Jtrader on Twitter @jtraderco

I would also Highly Recommend that you check out and watch many of the other good, interesting videos from Jtraderco on his YouTube Channel at: https://www.youtube.com/channel/UCfkXWb1vc82SZ9iOsDG4SIQ

What other Good Trading Videos, Webinars, etc. have You Found and would You Recommend?

Please Share them All herein for Everyone’s Benefit, ok?

I hope this all helps! Good Luck! and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

Simplest way to long stocks => https://www.youtube.com/watch?v=t8NcGfioV4I
by Jtrader on Twitter @jtraderco

I would also Highly Recommend that you check out and watch many of the other good, interesting videos from Jtraderco on his YouTube Channel at: https://www.youtube.com/channel/UCfkXWb1vc82SZ9iOsDG4SIQ

What other Good Trading Videos, Webinars, etc. have You Found and would You Recommend?

Please Share them All herein for Everyone’s Benefit, ok?

I hope this all helps! Good Luck! and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

My Watch List of COVID19 related Stocks as of 07/19/2020 include:

• $ADIL – Adial Pharmaceuticals, Inc. : Category = $COVID19 Antibody Test(s)
• $AIKI – AIkido Pharma Inc. : Category = $COVID19 Treatment(s)
• $AKER – Akers Biosciences, Inc. : Category = $COVID19 Vaccine
• $AMPE – Ampio Pharmaceuticals, Inc. : Category = $COVID19 Treatment(s)
• $ASTC – Astrotech Corporation : Category = $COVID19 Test(s)
• $ATOS – Atossa Genetics Inc. : Category = $COVID19 Treatment(s)
• $BHAT – Fujian Blue Hat Interactive Entertainment Technology Ltd. : Category = $COVID19 Online Education / Virtual School
• $BHAT – Fujian Blue Hat Interactive Entertainment Technology Ltd. : Category = $COVID19 Online Streaming
• $BHTG – BioHiTech Global, Inc. : Category = $COVID19 Disinfectant(s)
• $BOXL – Boxlight Corporation : Category = $COVID19 Online Education / Virtual School
• $CANF – Can-Fite BioPharma Ltd. : Category = $COVID19 Treatment(s)
• $CERS – Cerus Corporation : Category = $COVID19 Treatment(s)
• $CHFS – CHF Solutions, Inc. : Category = $COVID19 Treatment
• $CLBS – Caladrius Biosciences, Inc. : Category = $COVID19 Treatment(s)
• $CNDT – Conduent Incorporated : Category = $COVID19 Contact Tracing
• $COCP – Cocrystal Pharma, Inc. : Category = $COVID19 Treatment(s)
• $CREX – Creative Realities, Inc. : Category = $COVID19 Temperature Detection
• $CYCC – Cyclacel Pharmaceuticals, Inc. : Category = $COVID19 Treatment(s)
• $DVAX – Dynavax Technologies Corporation : Category = $COVID19 Vaccine
• $DYNT – Dynatronics Corporation : Category = $COVID19 Disinfectant(s)
• $EDNT – Edison Nation, Inc. : Category = $COVID19 PPE
• $ENZ – Enzo Biochem, Inc. : Category = $COVID19 Test(s)
• $HOTH – Hoth Therapeutics, Inc. : Category = $COVID19 Vaccine
• $HTBX – Heat Biologics, Inc. : Category = $COVID19 Vaccine
• $IBIO – iBio, Inc. : Category = $COVID19 Vaccine
• $IMV – IMV Inc. : Category = $COVID19 Vaccine
• $INO – Inovio Pharmaceuticals, Inc. : Category = $COVID19 Vaccine
• $LCTX – BioTime, Inc. : Category = $COVID19 Vaccine
• $LIFE – aTyr Pharma, Inc. : Category = $COVID19 Treatment(s)
• $MNOV – MediciNova, Inc. : Category = $COVID19 Treatment(s)
• $NOVN – Novan, Inc. : Category = $COVID19 Treatment(s)
• $ONCS – OncoSec Medical Incorporated : Category = $COVID19 Vaccine
• $OPK – OPKO Health, Inc. : Category = $COVID19 Test(s)
• $PDSB – PDS Biotechnology Corporation : Category = $COVID19 Vaccine
• $POAI – Predictive Oncology Inc. : Category = $COVID19 Vaccine
• $QLGN – Qualigen Therapeutics, Inc. : Category = $COVID19 Antibody Test(s)
• $SEAC – SeaChange International, Inc. : Category = $COVID19 Online Streaming
• $SINT – Sintx Technologies, Inc. : Category = $COVID19 Treatment(s)
• $SNGX – Soligenix, Inc. : Category = $COVID19 Vaccine
• $SPCB – SuperCom Ltd. : Category = $COVID19 Contact Tracing
• $THMO – ThermoGenesis Holdings, Inc. : Category = $COVID19 Antibody Test(s)
• $TLSA – Tiziana Life Sciences PLC : Category = $COVID19 Treatment(s)
• $TNXP – Tonix Pharmaceuticals Holding Corp. : Category = $COVID19 Vaccine
• $TRVN – Trevena, Inc. : Category = $COVID19 Treatment(s)
• $TTOO – T2 Biosystems, Inc. : Category = $COVID19 Test(s)
• $VBIV – VBI Vaccines Inc. : Category = $COVID19 Vaccine
• $VSTM – Verastem, Inc. : Category = $COVID19 Treatment(s)
• $VXRT – Vaxart, Inc. : Category = $COVID19 Vaccine(s)
• $ZVO – Zovio Inc : Category = $COVID19 = Catalyst

Please also Share Any and All other COVID19 related Stocks that you know of, and Why they should be considered COVID19 related, ideally with references/URLs, here in this Topic as well, for Everyone’s Mutual Benefit, ok?

I hope this all helps. Good Luck! and Have a Great Trading Week!

– Michael S. DeVries

[Michael DeVries]

My Watch List of COVID-19 related Stocks as of 07/11/2020 includes:

1. $ADIL – Adial Pharmaceuticals, Inc. – Category: COVID19 Antibody Test(s)
2. $AIKI – AIkido Pharma Inc. – Category: COVID19 Treatment(s)
3. $AKER – Akers Biosciences, Inc. – Category: COVID19 Vaccine
4. $AMPE – Ampio Pharmaceuticals, Inc. – Category: COVID19 Treatment(s)
5. $ASTC – Astrotech Corporation – Category: COVID19 Test(s)
6. $ATOS – Atossa Genetics Inc. – Category: COVID19 Treatment(s)
7. $BHAT – Fujian Blue Hat Interactive Entertainment Technology Ltd. – Category: COVID19 Online Education / Virtual School
8. $BHAT – Fujian Blue Hat Interactive Entertainment Technology Ltd. – Category: COVID19 Online Streaming
9. $BHTG – BioHiTech Global, Inc. – Category: COVID19 Disinfectant(s)
10. $CANF – Can-Fite BioPharma Ltd. – Category: COVID19 Treatment(s)
11. $CERS – Cerus Corporation – Category: COVID19 Treatment(s)
12. $CHFS – CHF Solutions, Inc. – Category: COVID19 Treatment
13. $CLBS – Caladrius Biosciences, Inc. – Category: COVID19 Treatment(s)
14. $CNDT – Conduent Incorporated – Category: COVID19 Contact Tracing
15. $COCP – Cocrystal Pharma, Inc. – Category: COVID19 Treatment(s)
16. $CREX – Creative Realities, Inc. – Category: COVID19 Temperature Detection
17. $CYCC – Cyclacel Pharmaceuticals, Inc. – Category: COVID19 Treatment(s)
18. $DVAX – Dynavax Technologies Corporation – Category: COVID19 Vaccine
19. $DYNT – Dynatronics Corporation – Category: COVID19 Disinfectant(s)
20. $EDNT – Edison Nation, Inc. – Category: COVID19 PPE
21. $HOTH – Hoth Therapeutics, Inc. – Category: COVID19 Vaccine
22. $HTBX – Heat Biologics, Inc. – Category: COVID19 Vaccine
23. $IBIO – iBio, Inc. – Category: COVID19 Vaccine
24. $INO – Inovio Pharmaceuticals, Inc. – Category: COVID19 Vaccine
25. $LCTX – BioTime, Inc. – Category: COVID19 Vaccine
26. $LIFE – aTyr Pharma, Inc. – Category: COVID19 Treatment(s)
27. $MNOV – MediciNova, Inc. – Category: COVID19 Treatment(s)
28. $OPK – OPKO Health, Inc. – Category: COVID19 Test(s)
29. $PDSB – PDS Biotechnology Corporation – Category: COVID19 Vaccine
30. $POAI – Predictive Oncology Inc. – Category: COVID19 Vaccine
31. $QLGN – Qualigen Therapeutics, Inc. – Category: COVID19 Antibody Test(s)
32. $SEAC – SeaChange International, Inc. – Category: COVID19 Online Streaming
33. $SINT – Sintx Technologies, Inc. – Category: COVID19 Treatment(s)
34. $SPCB – SuperCom Ltd. – Category: COVID19 Contact Tracing
35. $THMO – ThermoGenesis Holdings, Inc. – Category: COVID19 Antibody Test(s)
36. $TLSA – Tiziana Life Sciences PLC – Category: COVID19 Treatment(s)
37. $TNXP – Tonix Pharmaceuticals Holding Corp. – Category: COVID19 Vaccine
38. $TRVN – Trevena, Inc. – Category: COVID19 Treatment(s)
39. $TTOO – T2 Biosystems, Inc. – Category: COVID19 Test(s)
40. $VBIV – VBI Vaccines Inc. – Category: COVID19 Vaccine
41. $VXRT – Vaxart, Inc. – Category: COVID19 Vaccine(s)
42. $ZVO – Zovio Inc – Category: COVID19 = Catalyst

Please also Share Any and All other COVID-19 related Stocks that you know of, and Why they should be considered COVID-19 related, ideally with references/URLs, here in this Topic as well, for Everyone’s Mutual Benefit, ok?

I hope this all helps. Good Luck! And Have a Great Trading Week!

– Michael S. DeVries

[Michael DeVries]

The 5 Most Important Lessons I’ve Learned in 25 Years of Trading => https://realmoney.thestreet.com/investing/the-5-most-important-lessons-i-ve-learned-in-25-years-of-trading-15341196

What do you think of these 5 Lessons Learned that James says will help make you successful at trading?

Let’s discuss them all, and anything else that you believe may help make someone successful at trading, herein, ok?

I hope this all helps and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

The following are some of, IMHO, the Best / my Favorite Good (totally) FREE Stock Watch Lists, including:

• Swing Trade Stock Picks => http://blog.thevcf.com/forums/forum/stocks/swing-trading/
• AC Investor Blog => http://ac-investor.blogspot.com/
• FonsieTrader => https://fonsietraderblog.blogspot.com/

What are your Favorite Good (totally) FREE Stock Watch Lists?

I hope all of this helps! Good Luck! and Have a Great Trading Week!

– Michael S. DeVries

[Michael DeVries]

Thinking around corners. Planning in an uncertain future. – 03/16/20 => https://www.youtube.com/watch?v=qPutV3EMaFE&feature=youtu.be

by Adam Grimes, MarketLife => https://www.youtube.com/channel/UCMFsAM2qiVcQfYUuzoDaH1A

[Michael DeVries]

HOW TO LONG A CORONAVIRUS STOCK $ALT => https://www.youtube.com/watch?v=jP-_3w6Kab8
by Jtrader on Twitter @jtraderco, Channel on YouTube at: https://www.youtube.com/channel/UCfkXWb1vc82SZ9iOsDG4SIQ

What other Good Trading Videos, Webinars, etc. have You Found and would You Recommend RE: Trading Coronavirus Stocks?

Please Share them All herein for Everyone’s Benefit, ok?

I hope this all helps! Good Luck! and Have a Great Trading Day!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/23/2020 – 02/28/2020:

1) WWR – Westwater Resources, Inc.
a. Buy at <~ $1.96
b. Sell at >~ $9.25

2) ACHV – Achieve Life Sciences, Inc.
a. Buy at <~ $0.46
b. Sell at >~ $1.78
c. Catalysts:
1. Phase 1Phase 2 – Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers; 20200831; 20210228; https://ClinicalTrials.gov/show/NCT03761914
2. – The Pregnancy & Early Life Study; 20230601; 20230630; https://ClinicalTrials.gov/show/NCT03916874

3) ENZ – Enzo Biochem, Inc.
a. Buy at <~ $2.16
b. Sell at >~ $4.45

4) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/23/2020 – 02/28/2020, and Why?

Disclaimer

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 02/22/2020 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
2. $AVGR – Avinger, Inc. :
   1. Cash/sh = $0.88
3. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $4.39
4. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $0.76
5. $PHIO – Phio Pharmaceuticals Corp. :
   1. Cash/sh = $13.59
6. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $6.39
7. $TTPH – Tetraphase Pharmaceuticals, Inc. :
   1. Cash/sh = $4.16

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 02/22/2020 include:

1. $ARCW – ARC Group Worldwide, Inc. :
   1. Book/sh = $0.89
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $AVGR – Avinger, Inc. :
   1. Book/sh = $1.11
4. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.64
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $6.63
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $0.81
7. $IZEA – IZEA Worldwide, Inc. :
   1. Book/sh = $0.49
8. $KOPN – Kopin Corporation :
   1. Book/sh = $0.44
9. $NNDM – Nano Dimension Ltd. :
   1. Book/sh = $1.44
10. $PHIO – Phio Pharmaceuticals Corp. :
    1. Book/sh = $16.46
11. $ROSGQ – Rosetta Genomics Ltd. :
    1. Book/sh = $0.43
12. $SNCA – Seneca Biopharma, Inc. :
    1. Book/sh = $2.37
13. $SUNW – Sunworks, Inc. :
    1. Book/sh = $1.84
14. $TTPH – Tetraphase Pharmaceuticals, Inc. :
    1. Book/sh = $9.80
15. $VISL – Vislink Technologies, Inc. :
    1. Book/sh = $0.96
16. $VXRT – Vaxart, Inc. :
    1. Book/sh = $1.16
17. $YTEN – Yield10 Bioscience, Inc. :
    1. Book/sh = $8.37

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) and/or Trading Below Book (TBB) here in this Topic as well, ok?

#TradingBelowCash #TBC #TradingBelowBook #TBB #StockPicks #Stock #Market #Trading

[Michael DeVries]

Swing Trading – @kkernttb and @traderstewie – Sep 19, 2018 => https://www.youtube.com/watch?v=voZ7xCCCPkU

HOW TO TRADE PENNY STOCKS WITH TRENDSPIDER: BEST PATTERNS FOR DAYTRADING, Feb 9, 2020 => http://youtu.be/bxXhlH1bzME

Introduction to Python for Finance => https://www.youtube.com/watch?v=myFD0np9eys#action=share

Technical Analysis series videos! => https://www.youtube.com/playlist?list=PLJialFdc1V8cwdTW42Is-0FMiWEuwzVx5

08/13/2020:

What it takes to be a Profitable Trader WEBINAR => https://www.youtube.com/watch?v=AWeDFrj4puA&feature=emb_logo

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/10/2020 – 02/14/2020:

1) WWR – Westwater Resources, Inc.
a. Buy at <~ $1.96
b. Sell at >~ $9.25

2) VUZI – Vuzix Corporation
a. Buy at <~ $1.65
b. Sell at >~ $4.96

3) AVGR – Avinger, Inc. – Trading Below Cash
a. Buy at <~ $0.60
b. Sell at >~ $1.56

4) ARTW – Art’s-Way Manufacturing Co., Inc.
a. Buy at <~ $1.75
b. Sell at >~ $3.24

5) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

6) ACRX – AcelRx Pharmaceuticals, Inc.
a. Buy at <~ $1.64
b. Sell at >~ $2.50

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/10/2020 – 02/14/2020, and Why?

Disclaimer

[Michael DeVries]

Has anyone successfully developed integration with the E*TRADE API in AutoIt?

If so, then would you be willing and able to share some of your AutoIt code to do so with me? and/or help me successfully develop an AutoIt interface with the E*TRADE API?

Thank You and Have a Great Day!

– Michael S. DeVries

• This reply was modified 4 years, 9 months ago by Michael DeVries.
• This reply was modified 4 years, 9 months ago by Michael DeVries.

[Michael DeVries]

Has anyone successfully developed C# integration with the E*TRADE API?

If so, then would you be willing and able to share some of your C# code to do so with me? and/or help me successfully develop a C# interface with the E*TRADE API?

Thank You and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/06/2020 – 01/10/2020:

1) DSS – Document Security Systems, Inc.
a. Buy at <~ $0.25
b. Sell at >~ $0.57

2) CLIR – ClearSign Technologies Corporation
a. Buy at <~ $0.71
b. Sell at >~ $1.50

3) OXBR – Oxbridge Re Holdings Limited – Trading Below Cash
a. Buy at <~ $0.70
b. Sell at >~ $1.31

4) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

5) DNN – Denison Mines Corp.
a. Buy at <~ $0.38
b. Sell at >~ $0.52

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/06/2020 – 01/10/2020, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/16/2018 – 12/20/2019:

1) MNI – The McClatchy Company – Trading Below Cash
a. Buy at <~ $0.29
b. Sell at >~ $1.95

2) NVFY – Nova LifeStyle, Inc.
a. Buy at <~ $0.39
b. Sell at >~ $1.02

3) DSS – Document Security Systems, Inc.
a. Buy at <~ $0.25
b. Sell at >~ $0.57

4) SYN – Synthetic Biologics, Inc. – Trading Below Cash
a. Buy at <~ $0.36
b. Sell at >~ $0.55
c. Catalysts:
1. Phase 2 – A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis.; 20191117; 20200115; https://ClinicalTrials.gov/show/NCT03682705
2. NA – Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation; 20191231; 20201231; https://ClinicalTrials.gov/show/NCT03060928
3. Phase 3 – A Phase 3 Study to Compare ABT-494 to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20190707; 20210326; https://ClinicalTrials.gov/show/NCT03086343
4. Phase 4 – Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis; 20191001; 20201031; https://ClinicalTrials.gov/show/NCT01881308
5. NA – A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair; 20200103; 20210103; https://ClinicalTrials.gov/show/NCT03450473
6. Phase 1Phase 2 – A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.; 20200201; 20200229; https://ClinicalTrials.gov/show/NCT01789099
7. – Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism; 20200101; 20200101; https://ClinicalTrials.gov/show/NCT03076866
8. Phase 2 – Efficacy and Safety of SYN-010 in IBS-C; 20200101; 20200101; https://ClinicalTrials.gov/show/NCT03763175
9. Phase 4 – Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia; 20170901; 20200831; https://ClinicalTrials.gov/show/NCT02242526
10. NA – Influence of Aspirin on Human Gut Microbiota Composition and Metabolome; 20190228; 20191231; https://ClinicalTrials.gov/show/NCT03450317
11. Phase 3 – A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20170403; 20200806; https://ClinicalTrials.gov/show/NCT02706847
12. Phase 3 – A Study to Compare Upadacitinib (ABT-494) to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20170403; 20210916; https://ClinicalTrials.gov/show/NCT02706847
13. – Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway; 20190607; 20200131; https://ClinicalTrials.gov/show/NCT03799705
14. Phase 3 – Pre-pectoral Breast Reconstruction PART 1; 20190701; 20201231; https://ClinicalTrials.gov/show/NCT02830685
15. NA – Mesh Type in Ventral Hernia Repair; 20190331; 20220331; https://ClinicalTrials.gov/show/NCT03091790
16. Phase 3 – Pre-pectoral Breast Reconstruction PART 2; 20190601; 20201231; https://ClinicalTrials.gov/show/NCT02831426
17. Phase 3 – A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs ( SELECT-CHOICE ); 20200229; 20220607; https://ClinicalTrials.gov/show/NCT03086343
18. Phase 1 – CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia; 20210801; 20220801; https://ClinicalTrials.gov/show/NCT03854994
19. Phase 4 – Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders; 20210901; 20221130; https://ClinicalTrials.gov/show/NCT03227419
20. NA – Tissue Reinforcement of Incisional Closure Among High Risk Patients; 20201201; 20221231; https://ClinicalTrials.gov/show/NCT03148496
21. NA – Comparison of Arthroscopic Supraspinatus Tendon Tear Repair in Patients Over 60 Years With and Without Patch Augmentation.; 20210101; 20210101; https://ClinicalTrials.gov/show/NCT03511547
22. – Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings; 20230930; 20230930; https://ClinicalTrials.gov/show/NCT02758769
23. – Corrona Japan Rheumatoid Arthritis (RA) Registry; 21001201; 21001231; https://ClinicalTrials.gov/show/NCT02737449
24. Phase 4 – Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER); 20211231; 20211231; https://ClinicalTrials.gov/show/NCT03886038
25. NA – Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings; 20230930; 20230930; https://ClinicalTrials.gov/show/NCT02758769
26. – Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes.; 20200418; 20200418; https://ClinicalTrials.gov/show/NCT03123523
27. NA – New Diagnostic Approach for Congenital Toxoplasmosis; 20200501; 20201231; https://ClinicalTrials.gov/show/NCT03385499
28. NA – PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure; 20200301; 20250331; https://ClinicalTrials.gov/show/NCT03445936
29. NA – Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes.; 20200418; 20200418; https://ClinicalTrials.gov/show/NCT03123523
30. Phase 4 – Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA); 20200901; 20201230; https://ClinicalTrials.gov/show/NCT03652961
31. – Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients; 20201001; 20201031; https://ClinicalTrials.gov/show/NCT02476084
32. Phase 1Phase 2 – A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer; 20200701; 20200731; https://ClinicalTrials.gov/show/NCT01784913
33. Phase 2 – Oxandrolone Rotator Cuff Trial; 20200701; 20201231; https://ClinicalTrials.gov/show/NCT03091075

5) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.28
b. Sell at >~ $1.88

6) DNN – Denison Mines Corp.
a. Buy at <~ $0.38
b. Sell at >~ $0.52

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 12/16/2018 – 12/20/2019, and Why?

Disclaimer

[Michael DeVries]

How to Land a Job in IT
CareerSource Brevard at Groundswell
Oct. 22, 2019 from 6:00pm – 7:30pm

CareerSource Brevard is holding a meet-and-greet on “How to Land a Job in IT” at Groundswell, next Tuesday, Oct. 22, 2019, from 6:00pm – 7:30pm. The event if free, but you should register.

I will be speaking on “The Internet of Things (IoT)” to begin the evening. This is a topic that we’ve discussed at Big Data Florida before, and something that’s gaining a lot of traction. The introduction of 5G promises to significantly change the IoT landscape.
From the website:
Join us to meet and greet with IT employers and job seekers. You’ll have the opportunity to create an impression that employers will notice and gain first-hand knowledge of what IT employers are looking for. Attending this event will give you the confidence to ace your next job interview.

For more information, contact Gary Sulski, I.T. Sector Strategy Program Manager, at gsulski@careersourcebrevard.com.

Hope to see you there!

Scott Tilley
President
Big Data Florida
http://www.BigDataFlorida.org

 

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 09/02/2018 – 09/3062019:

1) VUZI – Vuzix Corporation
a. Buy at < ~ $1.77
b. Sell at >~ $4.96

2) CGIX – Cancer Genetics, Inc.
a. Buy at < ~ $0.09
b. Sell at >~ $0.34
c. Catalysts:
1. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
2. – Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT03648151
3. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
4. – The IMPACT Study – Identification of Men With a Genetic Predisposition to ProstAte Cancer; 20191201; 20211231; https://ClinicalTrials.gov/show/NCT00261456
5. – Genetics of Wilms Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies; 20191201; 20201231; https://ClinicalTrials.gov/show/NCT00503893
6. – Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT02917798
7. – DNA Repair and Genetic Susceptibility to Lung Cancer; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT00611598
8. – Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02542670
9. – Exploring the Link Between Cancer Genetics and PPSP; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT04007861
10. – Early Onset and Familial Gastric Cancer Registry; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00582257
11. – Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00579163

3) INUV – Inuvo, Inc.
a. Buy at < ~ $0.19
b. Sell at >~ $0.44

4) VJET – voxeljet AG
a. Buy at < ~ $1.52
b. Sell at >~ $2.45

5) KOPN – Kopin Corporation
a. Buy at < ~ $0.83
b. Sell at >~ $1.34

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 09/02/2018 – 09/3062019, and Why?

Disclaimer

[Michael DeVries]

Job Boards:

• KDnuggets Jobs in Analytics, Data Mining, and Data Science => https://www.kdnuggets.com/jobs/index.html
• Open Data Science job portal => https://jobs.opendatascience.com/

 

[Michael DeVries]

Articles – 20190729 – 1:
1) The march of the robots => https://economia.icaew.com/features/july-2019/the-march-of-the-robots
2) A Light Introduction to Transfer Learning for NLP => https://medium.com/dair-ai/a-light-introduction-to-transfer-learning-for-nlp-3e2cb56b48c8
3) Ten Trending Applications of Artificial Intelligence => https://hackernoon.com/artificial-intelligence-trends-to-watch-out-in-2019-b04q23dz5
4) The AI warfighter is coming, and it starts with dogfighting => https://www.fedscoop.com/ai-dogfighting-air-combat/
5) Pairing coders with artificial intelligence to write software => https://www.itproportal.com/features/pairing-coders-with-artificial-intelligence-to-write-software/
6) Winning With AI and Machine Learning Frameworks => https://www.valuecoders.com/blog/technology-and-apps/winning-with-ai-and-machine-learning-frameworks/?utm_source=Linkedin%2FSocialMediaSD%2Fai-ml-frameworks
7) The opportunities in enterprise RPA => https://venturebeat.com/2019/07/28/the-opportunities-in-enterprise-rpa/
8) 30+ Powerful Artificial Intelligence Examples you Need to Know => https://www.intelegain.com/30-powerful-artificial-intelligence-examples/
9) Jumping the last hurdle in business adoption of AI: unstructured data => https://www.itproportal.com/features/jumping-the-last-hurdle-in-business-adoption-of-ai-unstructured-data/
10) Why AI And Chatbots Need Personality => https://www.forbes.com/sites/bernardmarr/2019/08/02/why-ai-and-chatbots-need-personality/#1f8e743314f8
11) How AI could become an extension of your mind (Arnav Kapur | TED2019) (link: https://www.ted.com/talks/arnav_kapur_a_breakthrough_device_that_combines_mind_and_machine?utm_source=twitter.com&utm_medium=social&utm_campaign=tedspread) ted.com/talks/arnav_ka… via @TEDTalks
12) Want to survive the AI era? YOU have a simple choice to make… https://www.horsesforsources.com/survive-ai-choice_070719
13) Digital Workforce As A Part Of Digital Transformation: The Importance Of RPA => https://www.forbes.com/sites/forbestechcouncil/2019/01/31/digital-workforce-as-a-part-of-digital-transformation-the-importance-of-rpa/#708f784524e3
14) The Rise of Machine Learning to Manage Dark Data => https://www.technative.io/the-rise-of-machine-learning-to-manage-dark-data/
15) RPA and its expansion into AI: Driving a new era of business and IT alignment => https://www.information-age.com/rpa-ai-era-123476373/
16) Your AI Efforts Won’t Succeed Unless They Benefit Employees => https://hbr.org/2019/07/your-ai-efforts-wont-succeed-unless-they-benefit-employees
17) Intelligent Automation-Technology to Look Forward To => https://www.analyticsinsight.net/intelligent-automation-technology-to-look-forward-to/
18) How To Make Cognitive Automation Your Ally => https://www.brinknews.com/how-to-make-cognitive-automation-your-ally/
19) Prepare For The Business Of Tomorrow Today => https://www.forbes.com/sites/forbestechcouncil/2019/07/26/prepare-for-the-business-of-tomorrow-today/#5c4074a229e4

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 08/05/2018 – 08/09/2019:

1) MARK – Remark Holdings, Inc.
a. Buy at <~ $0.81
b. Sell at >~ $3.35

2) CGIX – Cancer Genetics, Inc.
a. Buy at <~ $0.13
b. Sell at >~ $0.34
c. Catalysts:
1. Phase 1Phase 2 – Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer; 20200220; 20200920; https://ClinicalTrials.gov/show/NCT02842125
2. – The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.; 20200301; 20210101; https://ClinicalTrials.gov/show/NCT03857477
3. NA – Testing a Culturally Adapted Telephone Genetic Counseling Intervention; 20200331; 20200331; https://ClinicalTrials.gov/show/NCT03959267
4. Phase 2 – Safety and Efficacy of Ad-p53 in Head and Neck Cancer; 20200101; 20200901; https://ClinicalTrials.gov/show/NCT03544723
5. – The IMPACT Study – Identification of Men With a Genetic Predisposition to ProstAte Cancer; 20191201; 20211231; https://ClinicalTrials.gov/show/NCT00261456
6. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
7. – Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT03648151
8. – Genetic Testing for Men With Metastatic Prostate Cancer; 20200821; 20200821; https://ClinicalTrials.gov/show/NCT03503097
9. NA – Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer; 20200901; 20260930; https://ClinicalTrials.gov/show/NCT02823652
10. NA – Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen); 20201130; 20231130; https://ClinicalTrials.gov/show/NCT03328091
11. – A Prognosis and Predicting Genetic Study of Lung Cancer; 20200801; 20370801; https://ClinicalTrials.gov/show/NCT03234179
12. NA – Cancer Health Assessments Reaching Many; 20200531; 20210531; https://ClinicalTrials.gov/show/NCT03426878
13. NA – Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins; 20200701; 20220731; https://ClinicalTrials.gov/show/NCT02965755
14. – Interest and Impact of Skin Cancer Genetic Testing; 20200801; 20200831; https://ClinicalTrials.gov/show/NCT02941900
15. – Genetics of Wilms Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies; 20191201; 20201231; https://ClinicalTrials.gov/show/NCT00503893
16. – The BARCODE 1 Study; 20181231; 20210429; https://ClinicalTrials.gov/show/NCT03158922
17. – Genetic Susceptibility to Bladder Cancer; 20190801; 20190831; https://ClinicalTrials.gov/show/NCT00848289
18. – Interest and Impact of Skin Cancer Genetic Testing; 20190801; 20190831; https://ClinicalTrials.gov/show/NCT02941900
19. – The BARCODE 1 Study; 20181231; 20210429; https://ClinicalTrials.gov/show/NCT03158922
20. NA – Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor – NGSKids; 20141117; 20201231; https://ClinicalTrials.gov/show/NCT02546453
21. – Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland; 20180331; 20220930; https://ClinicalTrials.gov/show/NCT03124212
22. – The BARCODE 1 Study; 20180414; 20210429; https://ClinicalTrials.gov/show/NCT03158922
23. – Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02542670
24. – Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT03934606
25. – Exploring the Link Between Cancer Genetics and PPSP; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT04007861
26. – Early Onset and Familial Gastric Cancer Registry; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00582257
27. – Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT02917798
28. – DNA Repair and Genetic Susceptibility to Lung Cancer; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT00611598
29. – Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00579163

3) SGLB – Sigma Labs, Inc.
a. Buy at <~ $0.70
b. Sell at >~ $1.50

4) PRTO – Proteon Therapeutics, Inc. – Trading Below Cash
a. Buy at <~ $0.35
b. Sell at >~ $0.65
c. Catalysts:
1. Phase 1 – Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK); 20190601; 20200131; https://ClinicalTrials.gov/show/NCT02956993
2. Phase 1 – Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02953496
3. Phase 3 – A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2); 20210201; 20210228; https://ClinicalTrials.gov/show/NCT02414841

5) INUV – Inuvo, Inc.
a. Buy at <~ $0.26
b. Sell at >~ $0.44

6) ATNM – Actinium Pharmaceuticals, Inc.
a. Buy at <~ $0.23
b. Sell at >~ $0.38
c. Catalysts:
1. Phase 3 – Study of Iomab-B Prior to Hematopoietic Cell Transplant vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia; 20191201; 20200630; https://ClinicalTrials.gov/show/NCT02665065
2. Phase 1 – A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma; 20191201; 20200131; https://ClinicalTrials.gov/show/NCT02998047
3. Phase 1Phase 2 – Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients; 20210101; 20230131; https://ClinicalTrials.gov/show/NCT03932318
4. Phase 1Phase 2 – Venetoclax and Lintuzumab-Ac225 in AML Patients; 20201101; 20221130; https://ClinicalTrials.gov/show/NCT03867682

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 08/05/2018 – 08/09/2019, and Why?

Disclaimer

[Michael DeVries]

The following are some References I have found from my further research into Content Management Systems (CMS) and Component Content Management Systems (CCMS):

General:

1. https://www.researchgate.net/publication/225191210_Integration_of_Natural_Language_Processing_Chains_in_Content_Management_Systems
2. Conversational Interfaces Need a Different Content Management System => https://chatbotsmagazine.com/conversational-interfaces-need-a-different-content-management-system-b105bb6f716
3. https://simplea.com/Articles/What-is-Intelligent-Content
   1. “Intelligent content is the road to digital maturity”
4. https://www.programmableweb.com/news/cope-create-once-publish-everywhere/2009/10/13
   1. “The goal of any CMS should be to gather enough information to present the content on any platform, in any presentation, at any time.”
5. Structured Content: The Key to Successful Chatbots and AI => https://www.ingeniux.com/company/blog/structured-content-the-key-to-successful-chatbots-and-ai
6. https://simplea.com/Articles/AI-Marketing-Chatbots-and-Your-CMS
   1. Building Chatbots with Intelligent Content => https://www.brighttalk.com/webcast/9273/270709
7. The Darwin Information Typing Architecture or Document Information Typing Architecture (DITA):
   1. https://en.wikipedia.org/wiki/Darwin_Information_Typing_Architecture
   2. Enabling Content in Chatbots and AI: Modeling Microcontent Structure for DITA => https://www.brighttalk.com/webcast/9273/285549?utm_source=brighttalk-portal&utm_medium=web&utm_content=\
8. Bringing Intelligence to Enterprise Content Management, Google Releases Document Understanding AI => https://www.infoq.com/news/2019/04/Google-Document-Understanding/
   1. Includes Candidate architecture image(s)
9. HOW ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING REVOLUTIONIZE DOCUMENT MANAGEMENT => https://www.armedia.com/blog/artificial-intelligence-machine-learning-document-management/
10. Top 25 Artificial Intelligence Use Cases for Content Management => http://www.econtentmag.com/Articles/Column/Cognito-Ergo-Sum/Top-25-Artificial-Intelligence-Use-Cases-for-Content-Management-124276.htm

Specifically RE: Content Management Systems (CMS):

 

Specifically RE: Component Component Management Systems (CCMS):

1. [Quickinar] What is a Component Content Management System? => https://www.brighttalk.com/webcast/9273/357184
2. How to Extract Content from Outdated Systems => https://www.brighttalk.com/webcast/9273/308209 \
   1. How the ISO Standard for CCMSs Impacts Your Information Architecture => https://www.brighttalk.com/webcast/9273/229045
3. https://thecontentwrangler.com/glossary/component-content-management-system/#

Resources:

1. https://thecontentwrangler.com/#
2. https://simplea.com
3. https://www.contentful.com/

Related V.I.B.E.S. Projects:

1. Automatically Generate Alternate Utterances and Synonyms for Natural Language Processing => http://blog.thevcf.com/forums/topic/automatically-generate-alternate-utterances-and-synonyms-for-natural-language-processing/
2. Conversational Interface CASE Tool => http://blog.thevcf.com/forums/topic/conversational-interface-case-tool/

What do you think about each of those articles, References, technologies, resources, etc. relative to Content Management Systems (CMS) and/or Component Component Management Systems (CCMS)?

Let’s discuss them all herein, ok?

What other articles, References, technologies, resources, etc. relative to Content Management Systems (CMS) and/or Component Component Management Systems (CCMS) have you all found?

Please Share them all herein for all of our mutual benefit, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

Did you know that E*TRADE has a usable API through which you may “Build your own trading app, flexibly analyze real time market data, and more” to further automate your trading tasks?

Please Reply herein if you have already developed an automated trading application using the E*TRADE API?
… and you experiences with it?
… and your lessons learned regarding how best to use the E*TRADE API to integrate with an automated trading application?

References:

1. https://developer.etrade.com/home
   1. https://developer.etrade.com/getting-started/developer-guides
2. Python rauth OAuth1Service:
   1. https://github.com/litl/rauth
   2. https://rauth.readthedocs.io/en/latest/
   3. https://rauth.readthedocs.io/en/latest/api/
   4. https://www.programcreek.com/python/example/99853/rauth.OAuth1Service

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

Articles – 20190624 – 1:
1) RPA: Stepping Stone or End-State Architecture Pattern? => https://www.thinkwgroup.com/rpa-stepping-stone-or-end-state-architecture-pattern
2) https://files.constantcontact.com/395d9f74701/56e6793c-c9ec-4d65-81fc-2ab72f031bd0.pdf
3) Google launches new search engine to help scientists find the datasets they need => https://www.theverge.com/2018/9/5/17822562/google-dataset-search-service-scholar-scientific-journal-open-data-access
4) Artificial Intelligence Continues Where Analytics Ends? => https://www.datasciencecentral.com/profiles/blogs/artificial-intelligence-continues-where-analytics-ends
5) 10 Steps to Disciplined Innovation => https://chiefexecutive.net/10-steps-disciplined-innovation/
6) Difference between Machine Learning and Traditional Programming => https://morioh.com/p/1063d43ef15e/machine-learning-vs-traditional-programming

[Author]

Posts